Back

Pirfenidone added to standard therapy for myocardial infarction further reduces left ventricular fibrosis: a preclinical study

21 May 2022 (09:40 - 10:25)
Organised by:
Congress Presentation Part of: From mechanisms to targets over the heart failure spectrum Heart Failure HFA Premium Access Heart Failure 2022

About the speaker

Photo
Doctor Alberto Aimo

Sant'Anna School of Advanced Studies, Pisa (Italy)

5 More presentations in this session

Presentation thumbnail
ATPIF-1 regulates the cardiac mitochondrial permeability transition pore and mitochondrial shape in mice
Mr P. Sanchez (Groningen, NL)
Abstract Slides
Presentation thumbnail
Effect of different post-myocardial infarction exercise training modality on cardiac calcium sensitivity and function
Professor J. Zhang (San Antonio, US)
Abstract Slides
Presentation thumbnail
The ketone body 3-hydroxybutyrate increases cardiac output through afterload reduction and not through increased left ventricular contractility
Doctor N. Gopalasingam (Herning, DK)
Abstract Slides
Presentation thumbnail
Endoplasmic reticulum stress as a therapeutic target for the treatment of cardiac and renal damage post myocardial infarction in the context of obesity
Miss B. Delgado Valero (Madrid, ES)
Abstract Slides
Presentation thumbnail
Pressure overload-induced cardiac hypertrophy stimulates tumour growth in tumour prone apc-min mice
Ms S. De Wit (Groningen, NL)
Abstract Slides

Access the full session

Session thumbnail
From mechanisms to targets over the heart failure spectrum

The Event

Event poster

Heart Failure 2022

21 May 2022 09:40 CET
You may be interested in
thumbnail
Congress Presentation
Fetal recapitulation and cellular stress in the evolution and progression of heart failure
thumbnail
Congress Session
Heart Failure 2025 highlights
thumbnail
Congress Session
Unspoken aetiologies of heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources